{"id":19077,"date":"2026-09-24T12:30:03","date_gmt":"2026-09-24T04:30:03","guid":{"rendered":"https:\/\/fotonmedix.com\/?p=19077"},"modified":"2026-09-24T12:30:03","modified_gmt":"2026-09-24T04:30:03","slug":"managing-canine-glaucoma-transscleral-ciliary-barriers","status":"publish","type":"post","link":"https:\/\/fotonmedix.com\/fr\/managing-canine-glaucoma-transscleral-ciliary-barriers.html","title":{"rendered":"Prise en charge du glaucome canin : barri\u00e8res ciliaires transscl\u00e9rales"},"content":{"rendered":"<p class=\"wp-block-paragraph\">La coagulation microvasculaire s\u00e9lective et l'\u00e9vacuation cibl\u00e9e des fluides bloquent la s\u00e9cr\u00e9tion aqueuse, tandis que les impulsions \u00e0 cycle de service contr\u00f4l\u00e9 emp\u00eachent la d\u00e9naturation du collag\u00e8ne scl\u00e9ral.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Un basset hound \u00e2g\u00e9 de neuf ans est amen\u00e9 au service d\u2019ophtalmologie v\u00e9t\u00e9rinaire pr\u00e9sentant un comportement de pression de la t\u00eate, un bl\u00e9pharospasme unilat\u00e9ral et des tremblements violents du c\u00f4t\u00e9 gauche du visage. L\u2019\u0153il gauche pr\u00e9sente une buphtalmie marqu\u00e9e, une congestion veineuse sombre le long des vaisseaux \u00e9piscl\u00e9raux, une opacit\u00e9 corn\u00e9enne diffuse de type \u00ab voile de bu\u00e9e \u00bb et une pupille fixe et dilat\u00e9e. Une tonom\u00e9trie par rebond TonoVet confirme une pression intraoculaire de 64 millim\u00e8tres de mercure. La stabilisation m\u00e9dicale imm\u00e9diate \u00e9choue : trois cycles cons\u00e9cutifs de traitement topique au latanoprost, d\u2019associations dorzolamide-timolol et de mannitol par voie intraveineuse ne parviennent \u00e0 r\u00e9duire la pression intraoculaire qu\u2019\u00e0 48 mmHg avant que celle-ci ne rebondisse, exposant la r\u00e9tine \u00e0 des l\u00e9sions isch\u00e9miques irr\u00e9versibles. Le propri\u00e9taire est paralys\u00e9 par la recommandation soudaine d\u2019une \u00e9nucl\u00e9ation, mais les options alternatives telles que la cyclocryoth\u00e9rapie comportent des risques notoires d\u2019uv\u00e9ite ant\u00e9rieure chronique, d\u2019hypotonie postop\u00e9ratoire s\u00e9v\u00e8re et de n\u00e9crose corn\u00e9enne. L\u2019\u00e9quipe chirurgicale est confront\u00e9e \u00e0 un obstacle clinique \u00e9vident : ablater le corps ciliaire s\u00e9cr\u00e9teur de mani\u00e8re non invasive \u00e0 travers une paroi oculaire intacte, sans br\u00fbler le collag\u00e8ne scl\u00e9ral ni provoquer de perforation du globe oculaire.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pour mettre fin \u00e0 l\u2019hypers\u00e9cr\u00e9tion d\u2019humeur aqueuse, il faut surmonter la courbe d\u2019att\u00e9nuation optique tr\u00e8s prononc\u00e9e de la couche scl\u00e9rale canine. La scl\u00e8re fibreuse est une matrice opaque constitu\u00e9e de lamelles denses et entrelac\u00e9es de collag\u00e8ne de type I, entour\u00e9es de glycosaminoglycanes hydrat\u00e9s, ce qui entra\u00eene une diffusion de Mie massive vers l\u2019avant et sur les c\u00f4t\u00e9s. Lorsque des photons de forte intensit\u00e9 traversent le bord p\u00e9rilimbal, l\u2019\u00e9nergie lumineuse superficielle se disperse rapidement dans le tissu scl\u00e9ral blanc, ne parvenant pas \u00e0 atteindre la fluence cible au niveau de l\u2019\u00e9pith\u00e9lium ciliaire pigment\u00e9. En l\u2019absence d\u2019absorption directe d\u2019\u00e9nergie \u00e0 l\u2019int\u00e9rieur du noyau vasculaire des processus ciliaires, la production de liquide aqueux, r\u00e9gul\u00e9e par l\u2019anhydrase carbonique, se poursuit sans interruption. L\u2019application de protocoles \u00e0 haute intensit\u00e9 de classe 4 \u00e0 longueurs d\u2019onde multiples r\u00e9sout ce goulot d\u2019\u00e9tranglement physique de l\u2019administration, transformant le traitement du glaucome chez le chien en une proc\u00e9dure pr\u00e9visible et pr\u00e9servant la vue, qui abaisse la pression intraoculaire tout en pr\u00e9servant l\u2019int\u00e9grit\u00e9 structurelle du globe oculaire.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Extinction optique \u00e0 travers la structure scl\u00e9rale et ciliaire<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">L'administration transscl\u00e9rale de photons dans le corps ciliaire canin se heurte \u00e0 une forte r\u00e9sistance optique. Contrairement aux milieux intraoculaires transparents tels que la corn\u00e9e et l'humeur aqueuse, la scl\u00e8re agit comme une barri\u00e8re opaque qui r\u00e9fl\u00e9chit la lumi\u00e8re. Les photons doivent traverser la conjonctive bulbaire, l\u2019\u00e9piscl\u00e8re et toute l\u2019\u00e9paisseur des lamelles fibreuses de la scl\u00e8re avant d\u2019atteindre le stroma ciliaire pigment\u00e9.<\/p>\n\n\n\n<pre class=\"wp-block-code\"><code>[Sonde transscl\u00e9rale \u00e0 haute intensit\u00e9]\n \u2502\n \u25bc (R\u00e9flexion sp\u00e9culaire et diffusion conjonctivale)\n [Conjonctive bulbaire et capsule de Tenon]\n \u2502\n                       \u25bc (Diffusion de Mie dans le collag\u00e8ne scl\u00e9ral entrelac\u00e9)\n [Matrice lamellaire fibreuse de la scl\u00e8re]\n \u2502\n \u25bc (Absorption cibl\u00e9e dans la m\u00e9lanine et l\u2019h\u00e9moglobine)\n [Stroma pigment\u00e9 du corps ciliaire]\n                       \u2502\n \u25bc (Coagulation photothermique &gt; arr\u00eat de la s\u00e9cr\u00e9tion)\n [\u00c9pith\u00e9lium ciliaire non pigment\u00e9 et touffes capillaires]\n<\/code><\/pre>\n\n\n\n<p class=\"wp-block-paragraph\">Les modalit\u00e9s \u00e0 faible intensit\u00e9 se dispersent au niveau des bords conjonctivaux externes, transformant la lumi\u00e8re en chaleur superficielle sans alt\u00e9rer l\u2019architecture ciliaire. Pour interrompre la s\u00e9cr\u00e9tion active d\u2019humeur aqueuse, la densit\u00e9 photonique doit atteindre les seuils th\u00e9rapeutiques au sein de la pars plicata et des processus ciliaires. Pour mettre en \u0153uvre un traitement efficace du glaucome chez le chien, il est n\u00e9cessaire d'adapter des chromophores sp\u00e9cifiques aux tissus aux vaisseaux ciliaires profonds plut\u00f4t que de se fier \u00e0 un r\u00e9chauffement externe diffus.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pour contourner les barri\u00e8res fibreuses stratifi\u00e9es, il est n\u00e9cessaire d'\u00e9mettre simultan\u00e9ment sur des pics spectraux compl\u00e9mentaires. La synchronisation de deux longueurs d'onde permet aux cliniciens de photocoaguler les microvaisseaux ciliaires et de r\u00e9duire l'\u00e9pith\u00e9lium hyperactif au cours d'une m\u00eame intervention chirurgicale.<\/p>\n\n\n\n<pre class=\"wp-block-code\"><code>Bande de longueurs d'onde adapt\u00e9e \u00e0 la couche oculaire cibl\u00e9e    Dynamique physiologique principale\n-----------------------------------------------------------------------------------------\nFaisceaux capillaires ciliaires 980 nm Cible : h\u00e9moglobine, thrombose microvasculaire\nStroma ciliaire interstitiel   1 470 nm R\u00e9sonance s\u00e9lective de l\u2019eau, r\u00e9tr\u00e9cissement du stroma\nCouche \u00e9pith\u00e9liale s\u00e9cr\u00e9toire    Rapport 980 nm \/ 1 470 nm     Ablation photothermique, suppression de l\u2019humeur aqueuse\n<\/code><\/pre>\n\n\n\n<h3 class=\"wp-block-heading\">Profil de l'h\u00e9moglobine \u00e0 980 nm et oblit\u00e9ration microvasculaire<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">La longueur d'onde de 980 nm co\u00efncide avec les spectres d'absorption de l'h\u00e9moglobine oxyg\u00e9n\u00e9e et d\u00e9soxyg\u00e9n\u00e9e au sein du r\u00e9seau microvasculaire ciliaire. Dans le glaucome aigu, le corps ciliaire maintient un flux sanguin intense afin de favoriser la production d'humeur aqueuse \u00e0 travers l'\u00e9pith\u00e9lium bicouche.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">L'absorption de photons \u00e0 980 nm provoque une coagulation photothermique cibl\u00e9e au sein des anse microcapillaires alimentant les processus ciliaires. Les globules rouges pr\u00e9sents dans la lumi\u00e8re vasculaire absorbent l'\u00e9nergie, induisant une thrombose localis\u00e9e et une occlusion microvasculaire sans br\u00fbler les couches de collag\u00e8ne environnantes. Cette occlusion vasculaire s\u00e9lective prive d'\u00e9nergie les m\u00e9canismes actifs de transport de l'ATPase sodium-potassium dans l'\u00e9pith\u00e9lium ciliaire non pigment\u00e9, interrompant ainsi la production primaire d'humeur aqueuse. Cette r\u00e9duction vasculaire cibl\u00e9e constitue le fondement du traitement non invasif du glaucome chez le chien, permettant de r\u00e9duire la pression intraoculaire sans endommager l'anatomie intraoculaire collat\u00e9rale.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">La voie d'absorption de l'eau \u00e0 1 470 nm dans la d\u00e9shydratation ciliaire<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Le stroma du corps ciliaire contient de grandes quantit\u00e9s de matrice extracellulaire hydrat\u00e9e, qui gonfle lors d'une inflammation intraoculaire aigu\u00eb. Le spectre \u00e0 1 470 nm cible sp\u00e9cifiquement les mol\u00e9cules d'eau libres et li\u00e9es pr\u00e9sentes dans cette matrice interstitielle, offrant ainsi un coefficient d'absorption nettement sup\u00e9rieur \u00e0 celui des bandes standard du proche infrarouge.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Lorsque des photons de 1 470 nm frappent le tissu ciliaire \u0153d\u00e9mateux, l'absorption cibl\u00e9e de l'eau entra\u00eene la d\u00e9naturation des prot\u00e9ines et un r\u00e9tr\u00e9cissement du stroma. Le volume interstitiel diminue rapidement, s\u00e9parant l\u2019\u00e9pith\u00e9lium s\u00e9cr\u00e9toire du noyau vasculaire sous-jacent et drainant le liquide inflammatoire localis\u00e9. La combinaison de la contraction stromale induite par la lumi\u00e8re \u00e0 1 470 nm et de la fermeture microvasculaire induite par la lumi\u00e8re \u00e0 980 nm entra\u00eene une baisse imm\u00e9diate de la production d\u2019humeur aqueuse, stabilisant ainsi le volume du globe oculaire et stoppant le d\u00e9collement progressif de la r\u00e9tine.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Conception du cycle de service pour la s\u00e9curit\u00e9 thermique scl\u00e9rale<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">L'\u00e9mission de photons de forte puissance \u00e0 travers une scl\u00e8re fine et riche en collag\u00e8ne comporte un risque r\u00e9el de l\u00e9sion thermique. Les fibres de collag\u00e8ne se d\u00e9naturent et fondent \u00e0 des temp\u00e9ratures \u00e9lev\u00e9es. Si une onde continue reste focalis\u00e9e sur le limbe, la chaleur s'accumule rapidement, entra\u00eenant un amincissement de la scl\u00e8re, une perforation sur toute l'\u00e9paisseur et un prolapsus uv\u00e9al catastrophique.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Les cycles de service dynamiques contr\u00f4l\u00e9s permettent d'\u00e9viter ces pics thermiques. La modulation du faisceau consiste \u00e0 alterner des salves d'impulsions de l'ordre de la microseconde avec des intervalles de relaxation thermique calibr\u00e9s.<\/p>\n\n\n\n<pre class=\"wp-block-code\"><code>Onde continue (emballement thermique au niveau des lamelles scl\u00e9rales) :\nPuissance \u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500\u2500 (Risque de perforation et de br\u00fblure de la scl\u00e8re)\n\nCycle de service dynamique \u00e0 impulsions (refroidissement structur\u00e9 de la scl\u00e8re) :\nPuissance \u250c\u2500\u2500\u2500\u2510    \u250c\u2500\u2500\u2500\u2510    \u250c\u2500\u2500\u2500\u2510    \u250c\u2500\u2500\u2500\u2510    \u250c\u2500\u2500\u2500\u2510\n      \u2502   \u2502    \u2502   \u2502    \u2502   \u2502    \u2502   \u2502    \u2502   \u2502   (Coagulation ciliaire profonde \/ Aucune br\u00fblure)\nBase  \u2518   \u2514\u2500\u2500\u2500\u2500\u2518   \u2514\u2500\u2500\u2500\u2500\u2518   \u2514\u2500\u2500\u2500\u2500\u2518   \u2514\u2500\u2500\u2500\u2500\u2518   \u2514\u2500\u2500\u2500\u2500\n |Ton|    Toff     |\n<\/code><\/pre>\n\n\n\n<p class=\"wp-block-paragraph\">Le collag\u00e8ne scl\u00e9ral perdant de la chaleur plus rapidement que les processus ciliaires sous-jacents, fortement vascularis\u00e9s, les cycles de fonctionnement dynamiques permettent aux cliniciens d\u2019appliquer une irradiance de cr\u00eate \u00e9lev\u00e9e \u00e0 travers la paroi externe de l\u2019\u0153il tout en maintenant des temp\u00e9ratures de surface s\u00fbres. Un fonctionnement avec des cycles de 20 % \u00e0 35 % permet une administration transscl\u00e9rale s\u00fbre et contr\u00f4l\u00e9e directement sur la circonf\u00e9rence p\u00e9rilimbique.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Le r\u00e9glage de la fr\u00e9quence des impulsions entre 10 hertz et 200 hertz permet d'adapter l'effet biologique : les fr\u00e9quences plus basses limitent l'\u00e9chauffement global des tissus, emp\u00eachant ainsi la propagation thermique vers le cristallin adjacent, tout en maintenant l'irradiance maximale n\u00e9cessaire \u00e0 la photocoagulation du stroma ciliaire profond.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Rapport de cas clinique sur le terrain<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Les donn\u00e9es ci-dessous sont issues des dossiers du service d'ophtalmologie v\u00e9t\u00e9rinaire et de microchirurgie ; elles pr\u00e9sentent les indicateurs de r\u00e9tablissement apr\u00e8s une cyclophotocoagulation chez un chien atteint d'un glaucome aigu r\u00e9fractaire.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Profil du patient et stadification diagnostique<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Num\u00e9ro de dossier : VOS-2026-2180<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Objet : Chien, Basset Hound<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u00c2ge : 9 ans et 1 mois<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Sexe : M\u00e2le (castr\u00e9)<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Poids : 26,4 kilogrammes<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Sympt\u00f4mes \u00e0 l'admission : douleur oculaire aigu\u00eb du c\u00f4t\u00e9 gauche, r\u00e9activit\u00e9 \u00e0 la pression sur la t\u00eate, larmoiement excessif, opacit\u00e9 corn\u00e9enne s\u00e9v\u00e8re, globe oculaire hypertrophi\u00e9, refus total de s'alimenter par voie orale.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Examen ophtalmologique : pression intraoculaire de l\u2019\u0153il gauche de 64 mmHg mesur\u00e9e par tonom\u00e9trie de rebond ; pupille mydriatique non r\u00e9active ; \u0153d\u00e8me corn\u00e9en diffus de l\u2019\u00e9pith\u00e9lium et du stroma ; engorgement \u00e9piscl\u00e9ral marqu\u00e9 ; r\u00e9action \u00e0 la menace n\u00e9gative ; r\u00e9flexe d\u2019\u00e9blouissement affaibli.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Stade diagnostique : glaucome secondaire aigu \u00e0 angle ferm\u00e9 avec crise d'hypertension oculaire s\u00e9v\u00e8re, secondaire \u00e0 une dysplasie s\u00e9v\u00e8re bilat\u00e9rale du ligament pectin\u00e9 (goniodyscopie de grade 3). Tonom\u00e9trie de l'\u0153il droit : 17 mmHg (angles de drainage irido-corn\u00e9ens \u00e9troits). Score de douleur avant traitement selon l'\u00e9chelle ophtalmologique modifi\u00e9e de Glasgow : 10 sur 12.<\/p>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><td><strong>Identifiant de session<\/strong><\/td><td><strong>Jour<\/strong><\/td><td><strong>Zone de livraison<\/strong><\/td><td><strong>Distribution des longueurs d'onde<\/strong><\/td><td><strong>Puissance de cr\u00eate (W)<\/strong><\/td><td><strong>Facteur de marche (%)<\/strong><\/td><td><strong>Fr\u00e9quence d'impulsion (Hz)<\/strong><\/td><td><strong>\u00c9nergie totale (J)<\/strong><\/td><td><strong>Observations cliniques<\/strong><\/td><\/tr><\/thead><tbody><tr><td>S-01<\/td><td>D-01<\/td><td>Arc transscl\u00e9ral \u00e0 270\u00b0<\/td><td>75% 980 nm \/ 25% 1 470 nm<\/td><td>2.5<\/td><td>25%<\/td><td>15<\/td><td>340<\/td><td>Sonde de contact plac\u00e9e \u00e0 3,5 mm en arri\u00e8re du limbe ; 26 points ; la PIO chute \u00e0 30 mmHg en 3 heures.<\/td><\/tr><tr><td>S-02<\/td><td>D-02<\/td><td>Arc dorsal transscl\u00e9ral<\/td><td>70% 980 nm \/ 30% 1 470 nm<\/td><td>2.5<\/td><td>25%<\/td><td>20<\/td><td>280<\/td><td>La congestion \u00e9piscl\u00e9rale s'att\u00e9nue ; l'opacification corn\u00e9enne s'estompe ; la PIO se stabilise \u00e0 24 mmHg sans mannitol.<\/td><\/tr><tr><td>S-03<\/td><td>D-05<\/td><td>Arc ventral transscl\u00e9ral<\/td><td>65% 980 nm \/ 35% 1 470 nm<\/td><td>2.8<\/td><td>30%<\/td><td>30<\/td><td>360<\/td><td>Le diam\u00e8tre de la pupille revient \u00e0 4 mm ; les r\u00e9flexes pupillaires \u00e0 la lumi\u00e8re, directs et consensuels, sont pr\u00e9sents.<\/td><\/tr><tr><td>S-04<\/td><td>D-09<\/td><td>Entretien circonf\u00e9rentiel<\/td><td>60% 980 nm \/ 40% 1 470 nm<\/td><td>2.8<\/td><td>30%<\/td><td>50<\/td><td>380<\/td><td>La transparence de la corn\u00e9e est enti\u00e8rement r\u00e9tablie ; la pression intraoculaire est de 17 mmHg ; le comportement alimentaire revient \u00e0 la normale.<\/td><\/tr><tr><td>S-05<\/td><td>J-14<\/td><td>Secteurs ciliaires cibl\u00e9s<\/td><td>50% 980 nm \/ 50% 1 470 nm<\/td><td>3.0<\/td><td>30%<\/td><td>100<\/td><td>400<\/td><td>Vue fundus claire ; r\u00e9flexe tap\u00e9tal net ; concavit\u00e9 physiologique du nerf optique pr\u00e9serv\u00e9e.<\/td><\/tr><tr><td>S-06<\/td><td>J-21<\/td><td>Renfort transscl\u00e9ral<\/td><td>50% 980 nm \/ 50% 1 470 nm<\/td><td>3.0<\/td><td>30%<\/td><td>150<\/td><td>400<\/td><td>Voie d'\u00e9coulement stable ; calibre des vaisseaux \u00e9piscl\u00e9raux revenu \u00e0 la normale par rapport \u00e0 la valeur de r\u00e9f\u00e9rence.<\/td><\/tr><tr><td>S-07<\/td><td>J-30<\/td><td>D\u00e9compression p\u00e9rioculaire<\/td><td>50% 980 nm \/ 50% 1 470 nm<\/td><td>2.5<\/td><td>25%<\/td><td>Dynamique<\/td><td>320<\/td><td>R\u00e9ponse \u00e0 la menace intacte ; la PIO est de 16 mmHg des deux c\u00f4t\u00e9s sous collyre \u00e0 faible dose.<\/td><\/tr><tr><td>S-08<\/td><td>D-45<\/td><td>Audit de contr\u00f4le \u00e0 long terme<\/td><td>50% 980 nm \/ 50% 1 470 nm<\/td><td>2.2<\/td><td>20%<\/td><td>Dynamique<\/td><td>260<\/td><td>Sym\u00e9trie globulaire parfaitement pr\u00e9serv\u00e9e ; score de Glasgow = 0 ; vision fonctionnelle pr\u00e9serv\u00e9e.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h3 class=\"wp-block-heading\">Indicateurs objectifs de r\u00e9tablissement fonctionnel<\/h3>\n\n\n\n<pre class=\"wp-block-code\"><code>Jour 1 (Admission en urgence)\n[Pression intraoculaire : 64 mmHg] \u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\n[\u00c9chelle de douleur : 10\/12] \u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2588\u2591\u2591\u2591\u2591\n\nJour 9 (bilan \u00e0 mi-parcours)\n[Pression intraoculaire : 17 mmHg] \u2588\u2588\u2588\u2588\u2588\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\n[Score de douleur : 2\/12] \u2588\u2588\u2588\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\n\nJour 45 (Sortie du protocole)\n[Pression intraoculaire : 16 mmHg] \u2588\u2588\u2588\u2588\u2588\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\n[Score de douleur : 0\/12] \u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\u2591\n<\/code><\/pre>\n\n\n\n<p class=\"wp-block-paragraph\">Au 45e jour, le patient a atteint une stabilisation oculaire compl\u00e8te. La pression intraoculaire de l\u2019\u0153il gauche s\u2019est stabilis\u00e9e \u00e0 16 mmHg, s\u2019\u00e9quilibrant ainsi avec celle de l\u2019\u0153il droit non atteint, sans qu\u2019il soit n\u00e9cessaire de recourir \u00e0 des agents d\u00e9shydratants syst\u00e9miques. Le score sur l\u2019\u00e9chelle de douleur ophtalmique modifi\u00e9e de Glasgow est pass\u00e9 de 10 \u00e0 0, confirmant la disparition des c\u00e9phal\u00e9es s\u00e9v\u00e8res et de la photophobie.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">La disparition compl\u00e8te de l'\u0153d\u00e8me du stroma corn\u00e9en a permis de r\u00e9tablir une visualisation totale de la chambre ant\u00e9rieure, ce qui a permis un examen direct du fond de l'\u0153il et a confirm\u00e9 que l'architecture du disque optique \u00e9tait intacte. Des r\u00e9ponses positives aux tests de menace et d'\u00e9blouissement ont confirm\u00e9 la pr\u00e9servation de la vision fonctionnelle, \u00e9vitant ainsi avec succ\u00e8s une \u00e9nucl\u00e9ation.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Avantages pratiques par rapport aux m\u00e9thodes traditionnelles<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">La prise en charge du glaucome canin pose de s\u00e9rieux dilemmes cliniques dans la pratique v\u00e9t\u00e9rinaire. La stabilisation m\u00e9dicale d\u2019urgence \u00e0 l\u2019aide de collyres hypotenseurs et de diur\u00e9tiques osmotiques permet rarement un contr\u00f4le durable ; elle ne constitue qu\u2019une mesure temporaire avant que la pression intraoculaire ne remonte dangereusement. Les approches chirurgicales conventionnelles pr\u00e9sentent de lourds inconv\u00e9nients cliniques : les chirurgies de filtration \u00e0 ciel ouvert \u00e9chouent fr\u00e9quemment en raison d\u2019une fibroplasie postop\u00e9ratoire agressive, tandis que l\u2019\u00e9nucl\u00e9ation d\u00e9figure d\u00e9finitivement le patient et a un impact \u00e9motionnel d\u00e9vastateur sur les propri\u00e9taires d\u2019animaux de compagnie. L\u2019ablation chimique du corps ciliaire par injections intravitr\u00e9ennes comporte des risques \u00e9lev\u00e9s de phthisis bulbi permanent, d\u2019hyph\u00e9ma et d\u2019endophtalmie chronique.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Les appareils de phototh\u00e9rapie de faible puissance ne donnent pas les r\u00e9sultats escompt\u00e9s dans le cadre des soins chirurgicaux ophtalmologiques. Les appareils de faible puissance ne parviennent pas \u00e0 fournir une densit\u00e9 d'\u00e9nergie suffisante \u00e0 travers le tissu scl\u00e9ral dense pour atteindre les processus ciliaires ; ils ne produisent qu'une chaleur superficielle qui aggrave l'inflammation intraoculaire sans pour autant freiner la production d'humeur aqueuse.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Les protocoles multi-longueurs d'onde de classe 4 \u00e0 haute puissance permettent de surmonter ces impasses th\u00e9rapeutiques. La d\u00e9livrance d\u2019une puissance de cr\u00eate contr\u00f4l\u00e9e gr\u00e2ce \u00e0 un \u00e9quilibre entre les longueurs d\u2019onde de 980 nm et 1 470 nm permet une cyclophotocoagulation transscl\u00e9rale en moins de cinq minutes par quadrant. Cette d\u00e9livrance pr\u00e9cise permet aux chirurgiens v\u00e9t\u00e9rinaires de fermer les vaisseaux ciliaires et de r\u00e9duire rapidement le tissu s\u00e9cr\u00e9toire, \u00e9vitant ainsi un traumatisme tissulaire important.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Le mode de pulsation \u00e0 cycle de service dynamique prot\u00e8ge le collag\u00e8ne scl\u00e9ral externe, \u00e9liminant ainsi les risques de perforation scl\u00e9rale, de br\u00fblures thermiques corn\u00e9ennes et de formation de cataracte, fr\u00e9quents avec les anciens lasers \u00e0 onde continue. La pression intraoculaire diminue de mani\u00e8re pr\u00e9visible dans les heures qui suivent la premi\u00e8re s\u00e9ance, soulageant ainsi les douleurs c\u00e9phaliques atroces et pr\u00e9servant l'architecture oculaire. Pour les cabinets v\u00e9t\u00e9rinaires, l'association d'une ablation ciliaire non invasive \u00e0 un contr\u00f4le fiable de la pression intraoculaire transforme les urgences ophtalmologiques complexes en un service clinique efficace permettant de pr\u00e9server la vue.<\/p>","protected":false},"excerpt":{"rendered":"<p>Selective microvascular coagulation and targeted fluid evacuation shutdown aqueous secretion while gated duty cycle pulsing prevents scleral collagen denaturation. A nine-year-old Basset Hound arrives at the veterinary ophthalmology suite with head pressing, unilateral blepharospasm, and violent trembling on the left side of its face. The left eye exhibits prominent buphthalmia, dark venous engorgement along the [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"themepark_post_bcolor":"#f5f5f5","themepark_post_width":"1022px","themepark_post_img":"","themepark_post_img_po":"left","themepark_post_img_re":false,"themepark_post_img_cover":false,"themepark_post_img_fixed":false,"themepark_post_hide_title":false,"themepark_post_main_b":"","themepark_post_main_p":100,"themepark_paddingblock":false,"slim_seo":{"title":"Traitement de la tendinite des fl\u00e9chisseurs profonds chez les chevaux de haut niveau","description":"Les lasers de classe 4 \u00e0 double longueur d'onde pr\u00e9viennent le blocage thermique des tissus et ciblent les l\u00e9sions tendineuses isch\u00e9miques profondes afin de favoriser une r\u00e9cup\u00e9ration rapide du syst\u00e8me musculo-squelettique chez le cheval."},"_geo_short_summary":"","_geo_structured_desc":"","_geo_faqs":"","_geo_key_points":"","_geo_target_audience":"","_geo_content_type":"","_geo_last_modified":"","_geo_version":0,"themepark_seo_title":"","themepark_seo_description":"","_slim_seo_primary_term_category":0,"_slim_seo_primary_term_post_tag":0,"footnotes":""},"categories":[19],"tags":[],"class_list":["post-19077","post","type-post","status-publish","format-standard","hentry","category-industry-news"],"metadata":{"_edit_lock":["1789892138:1"],"_edit_last":["1"],"_aioseo_title":[null],"_aioseo_description":[null],"_aioseo_og_title":[""],"_aioseo_og_description":[""],"_aioseo_og_article_section":[""],"_aioseo_twitter_title":[""],"_aioseo_twitter_description":[""],"_aioseo_keywords":["a:0:{}"],"_aioseo_og_article_tags":["a:0:{}"],"catce":["sidebar-widgets4"],"slim_seo":["a:2:{s:5:\"title\";s:57:\"Healing Deep Flexor Tendonitis in High-Performance Horses\";s:11:\"description\";s:142:\"Dual-wavelength Class 4 lasers prevent tissue thermal stall and target deep ischemic tendon lesions for rapid equine musculoskeletal recovery.\";}"],"views":["125"],"wpil_sync_report3":["0"]},"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.3 - aioseo.com -->\n\t<meta name=\"description\" content=\"Selective microvascular coagulation and targeted fluid evacuation shutdown aqueous secretion while gated duty cycle pulsing prevents scleral collagen denaturation. A nine-year-old Basset Hound arrives at the veterinary ophthalmology suite with head pressing, unilateral blepharospasm, and violent trembling on the left side of its face. The left eye exhibits prominent buphthalmia, dark venous engorgement along the\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"fengmaiadmin\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/fotonmedix.com\/fr\/managing-canine-glaucoma-transscleral-ciliary-barriers.html\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.3\" \/>\n\t\t<meta property=\"og:locale\" content=\"fr_FR\" \/>\n\t\t<meta property=\"og:site_name\" content=\"FotonMedix |\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Managing Canine Glaucoma Transscleral Ciliary Barriers | FotonMedix\" \/>\n\t\t<meta property=\"og:description\" content=\"Selective microvascular coagulation and targeted fluid evacuation shutdown aqueous secretion while gated duty cycle pulsing prevents scleral collagen denaturation. A nine-year-old Basset Hound arrives at the veterinary ophthalmology suite with head pressing, unilateral blepharospasm, and violent trembling on the left side of its face. The left eye exhibits prominent buphthalmia, dark venous engorgement along the\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/fotonmedix.com\/fr\/managing-canine-glaucoma-transscleral-ciliary-barriers.html\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-09-24T04:30:03+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-09-24T04:30:03+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Managing Canine Glaucoma Transscleral Ciliary Barriers | FotonMedix\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Selective microvascular coagulation and targeted fluid evacuation shutdown aqueous secretion while gated duty cycle pulsing prevents scleral collagen denaturation. A nine-year-old Basset Hound arrives at the veterinary ophthalmology suite with head pressing, unilateral blepharospasm, and violent trembling on the left side of its face. The left eye exhibits prominent buphthalmia, dark venous engorgement along the\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#blogposting\",\"name\":\"Managing Canine Glaucoma Transscleral Ciliary Barriers | FotonMedix\",\"headline\":\"Managing Canine Glaucoma Transscleral Ciliary Barriers\",\"author\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/author\\\/fengmaiadmin#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/#person\"},\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#articleImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/251e3799fc0e3aa28192a4ec864ea6d0715aeaa153f1a97df75ebe456ebdc0e4?s=96&d=wavatar&r=g\",\"width\":96,\"height\":96,\"caption\":\"fengmaiadmin\"},\"datePublished\":\"2026-09-24T12:30:03+08:00\",\"dateModified\":\"2026-09-24T12:30:03+08:00\",\"inLanguage\":\"fr-FR\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#webpage\"},\"articleSection\":\"Industry News\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/categorie\\\/nouvelles#listItem\",\"name\":\"News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/categorie\\\/nouvelles#listItem\",\"position\":2,\"name\":\"News\",\"item\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/categorie\\\/nouvelles\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/categorie\\\/nouvelles\\\/industry-news#listItem\",\"name\":\"Industry News\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/categorie\\\/nouvelles\\\/industry-news#listItem\",\"position\":3,\"name\":\"Industry News\",\"item\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/categorie\\\/nouvelles\\\/industry-news\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#listItem\",\"name\":\"Managing Canine Glaucoma Transscleral Ciliary Barriers\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/categorie\\\/nouvelles#listItem\",\"name\":\"News\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#listItem\",\"position\":4,\"name\":\"Managing Canine Glaucoma Transscleral Ciliary Barriers\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/categorie\\\/nouvelles\\\/industry-news#listItem\",\"name\":\"Industry News\"}}]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/author\\\/fengmaiadmin#author\",\"url\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/author\\\/fengmaiadmin\",\"name\":\"fengmaiadmin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/251e3799fc0e3aa28192a4ec864ea6d0715aeaa153f1a97df75ebe456ebdc0e4?s=96&d=wavatar&r=g\",\"width\":96,\"height\":96,\"caption\":\"fengmaiadmin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#webpage\",\"url\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/managing-canine-glaucoma-transscleral-ciliary-barriers.html\",\"name\":\"Managing Canine Glaucoma Transscleral Ciliary Barriers | FotonMedix\",\"description\":\"Selective microvascular coagulation and targeted fluid evacuation shutdown aqueous secretion while gated duty cycle pulsing prevents scleral collagen denaturation. A nine-year-old Basset Hound arrives at the veterinary ophthalmology suite with head pressing, unilateral blepharospasm, and violent trembling on the left side of its face. The left eye exhibits prominent buphthalmia, dark venous engorgement along the\",\"inLanguage\":\"fr-FR\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/author\\\/fengmaiadmin#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/author\\\/fengmaiadmin#author\"},\"datePublished\":\"2026-09-24T12:30:03+08:00\",\"dateModified\":\"2026-09-24T12:30:03+08:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/\",\"name\":\"FotonMedix\",\"inLanguage\":\"fr-FR\",\"publisher\":{\"@id\":\"https:\\\/\\\/fotonmedix.com\\\/fr\\\/#person\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Prise en charge du glaucome canin : barri\u00e8res ciliaires transscl\u00e9rales | FotonMedix","description":"La coagulation microvasculaire s\u00e9lective et l'\u00e9vacuation cibl\u00e9e des fluides bloquent la s\u00e9cr\u00e9tion aqueuse, tandis que les impulsions \u00e0 cycle de service contr\u00f4l\u00e9 emp\u00eachent la d\u00e9naturation du collag\u00e8ne scl\u00e9ral. Un basset hound \u00e2g\u00e9 de neuf ans est amen\u00e9 au service d\u2019ophtalmologie v\u00e9t\u00e9rinaire pr\u00e9sentant un comportement de pression de la t\u00eate, un bl\u00e9pharospasme unilat\u00e9ral et des tremblements violents du c\u00f4t\u00e9 gauche du visage. L\u2019\u0153il gauche pr\u00e9sente une buphtalmie marqu\u00e9e, une congestion veineuse sombre le long de la","canonical_url":"https:\/\/fotonmedix.com\/fr\/managing-canine-glaucoma-transscleral-ciliary-barriers.html","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/fotonmedix.com\/fr\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#blogposting","name":"Managing Canine Glaucoma Transscleral Ciliary Barriers | FotonMedix","headline":"Managing Canine Glaucoma Transscleral Ciliary Barriers","author":{"@id":"https:\/\/fotonmedix.com\/fr\/author\/fengmaiadmin#author"},"publisher":{"@id":"https:\/\/fotonmedix.com\/fr\/#person"},"image":{"@type":"ImageObject","@id":"https:\/\/fotonmedix.com\/fr\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#articleImage","url":"https:\/\/secure.gravatar.com\/avatar\/251e3799fc0e3aa28192a4ec864ea6d0715aeaa153f1a97df75ebe456ebdc0e4?s=96&d=wavatar&r=g","width":96,"height":96,"caption":"fengmaiadmin"},"datePublished":"2026-09-24T12:30:03+08:00","dateModified":"2026-09-24T12:30:03+08:00","inLanguage":"fr-FR","mainEntityOfPage":{"@id":"https:\/\/fotonmedix.com\/fr\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#webpage"},"isPartOf":{"@id":"https:\/\/fotonmedix.com\/fr\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#webpage"},"articleSection":"Industry News"},{"@type":"BreadcrumbList","@id":"https:\/\/fotonmedix.com\/fr\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/fr\/#listItem","position":1,"name":"Home","item":"https:\/\/fotonmedix.com\/fr\/","nextItem":{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/fr\/categorie\/nouvelles#listItem","name":"News"}},{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/fr\/categorie\/nouvelles#listItem","position":2,"name":"News","item":"https:\/\/fotonmedix.com\/fr\/categorie\/nouvelles","nextItem":{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/fr\/categorie\/nouvelles\/industry-news#listItem","name":"Industry News"},"previousItem":{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/fr\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/fr\/categorie\/nouvelles\/industry-news#listItem","position":3,"name":"Industry News","item":"https:\/\/fotonmedix.com\/fr\/categorie\/nouvelles\/industry-news","nextItem":{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/fr\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#listItem","name":"Managing Canine Glaucoma Transscleral Ciliary Barriers"},"previousItem":{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/fr\/categorie\/nouvelles#listItem","name":"News"}},{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/fr\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#listItem","position":4,"name":"Managing Canine Glaucoma Transscleral Ciliary Barriers","previousItem":{"@type":"ListItem","@id":"https:\/\/fotonmedix.com\/fr\/categorie\/nouvelles\/industry-news#listItem","name":"Industry News"}}]},{"@type":"Person","@id":"https:\/\/fotonmedix.com\/fr\/author\/fengmaiadmin#author","url":"https:\/\/fotonmedix.com\/fr\/author\/fengmaiadmin","name":"fengmaiadmin","image":{"@type":"ImageObject","@id":"https:\/\/fotonmedix.com\/fr\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/251e3799fc0e3aa28192a4ec864ea6d0715aeaa153f1a97df75ebe456ebdc0e4?s=96&d=wavatar&r=g","width":96,"height":96,"caption":"fengmaiadmin"}},{"@type":"WebPage","@id":"https:\/\/fotonmedix.com\/fr\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#webpage","url":"https:\/\/fotonmedix.com\/fr\/managing-canine-glaucoma-transscleral-ciliary-barriers.html","name":"Managing Canine Glaucoma Transscleral Ciliary Barriers | FotonMedix","description":"Selective microvascular coagulation and targeted fluid evacuation shutdown aqueous secretion while gated duty cycle pulsing prevents scleral collagen denaturation. A nine-year-old Basset Hound arrives at the veterinary ophthalmology suite with head pressing, unilateral blepharospasm, and violent trembling on the left side of its face. The left eye exhibits prominent buphthalmia, dark venous engorgement along the","inLanguage":"fr-FR","isPartOf":{"@id":"https:\/\/fotonmedix.com\/fr\/#website"},"breadcrumb":{"@id":"https:\/\/fotonmedix.com\/fr\/managing-canine-glaucoma-transscleral-ciliary-barriers.html#breadcrumblist"},"author":{"@id":"https:\/\/fotonmedix.com\/fr\/author\/fengmaiadmin#author"},"creator":{"@id":"https:\/\/fotonmedix.com\/fr\/author\/fengmaiadmin#author"},"datePublished":"2026-09-24T12:30:03+08:00","dateModified":"2026-09-24T12:30:03+08:00"},{"@type":"WebSite","@id":"https:\/\/fotonmedix.com\/fr\/#website","url":"https:\/\/fotonmedix.com\/fr\/","name":"FotonMedix","inLanguage":"fr-FR","publisher":{"@id":"https:\/\/fotonmedix.com\/fr\/#person"}}]},"og:locale":"fr_FR","og:site_name":"FotonMedix |","og:type":"article","og:title":"Managing Canine Glaucoma Transscleral Ciliary Barriers | FotonMedix","og:description":"Selective microvascular coagulation and targeted fluid evacuation shutdown aqueous secretion while gated duty cycle pulsing prevents scleral collagen denaturation. A nine-year-old Basset Hound arrives at the veterinary ophthalmology suite with head pressing, unilateral blepharospasm, and violent trembling on the left side of its face. The left eye exhibits prominent buphthalmia, dark venous engorgement along the","og:url":"https:\/\/fotonmedix.com\/fr\/managing-canine-glaucoma-transscleral-ciliary-barriers.html","article:published_time":"2026-09-24T04:30:03+00:00","article:modified_time":"2026-09-24T04:30:03+00:00","twitter:card":"summary_large_image","twitter:title":"Managing Canine Glaucoma Transscleral Ciliary Barriers | FotonMedix","twitter:description":"Selective microvascular coagulation and targeted fluid evacuation shutdown aqueous secretion while gated duty cycle pulsing prevents scleral collagen denaturation. A nine-year-old Basset Hound arrives at the veterinary ophthalmology suite with head pressing, unilateral blepharospasm, and violent trembling on the left side of its face. The left eye exhibits prominent buphthalmia, dark venous engorgement along the"},"aioseo_meta_data":{"post_id":"19077","title":null,"description":null,"keywords":null,"keyphrases":{"focus":{"keyphrase":"","score":0,"analysis":{"keyphraseInTitle":{"score":0,"maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"seo_analyzer_scan_date":null,"breadcrumb_settings":null,"limit_modified_date":false,"reviewed_by":null,"open_ai":null,"ai":{"faqs":[],"keyPoints":[],"schemas":[],"titles":[],"descriptions":[],"socialPosts":{"email":{"subject":"","preview":"","content":""},"linkedin":[],"twitter":[],"facebook":[],"instagram":[]}},"created":"2026-09-20 08:14:58","updated":"2026-09-24 04:30:40","focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/fotonmedix.com\/fr\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/fotonmedix.com\/fr\/categorie\/nouvelles\" title=\"News\">News<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/fotonmedix.com\/fr\/categorie\/nouvelles\/industry-news\" title=\"Industry News\">Industry News<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tManaging Canine Glaucoma Transscleral Ciliary Barriers\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/fotonmedix.com\/fr\/"},{"label":"News","link":"https:\/\/fotonmedix.com\/fr\/categorie\/nouvelles"},{"label":"Industry News","link":"https:\/\/fotonmedix.com\/fr\/categorie\/nouvelles\/industry-news"},{"label":"Managing Canine Glaucoma Transscleral Ciliary Barriers","link":"https:\/\/fotonmedix.com\/fr\/managing-canine-glaucoma-transscleral-ciliary-barriers.html"}],"medium_url":false,"thumbnail_url":false,"full_url":false,"_links":{"self":[{"href":"https:\/\/fotonmedix.com\/fr\/wp-json\/wp\/v2\/posts\/19077","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fotonmedix.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fotonmedix.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fotonmedix.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fotonmedix.com\/fr\/wp-json\/wp\/v2\/comments?post=19077"}],"version-history":[{"count":0,"href":"https:\/\/fotonmedix.com\/fr\/wp-json\/wp\/v2\/posts\/19077\/revisions"}],"wp:attachment":[{"href":"https:\/\/fotonmedix.com\/fr\/wp-json\/wp\/v2\/media?parent=19077"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fotonmedix.com\/fr\/wp-json\/wp\/v2\/categories?post=19077"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fotonmedix.com\/fr\/wp-json\/wp\/v2\/tags?post=19077"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}